Disease modifying treatments for Parkinson’s disease – an update
| Autor: | Vijay Chandran, Donald G Grosset |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Advances in Clinical Neuroscience & Rehabilitation, Vol , Iss (2021) |
| Druh dokumentu: | article |
| ISSN: | 1473-9348 2397-267X 67994342 |
| DOI: | 10.47795/JHQT7239 |
| Popis: | An improved understanding of the pathological processes leading to neurodegeneration in Parkinson’s disease (PD) is leading to the development of a number of disease modifying agents. These include both novel and repurposed drugs. Some of these disease modifying therapies act on cellular targets that have been identified by genetic mutations, while others act on other cellular process which we know are affected in PD. This review provides an update on the progress in the field, and highlights some areas of special interest. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|